MeSH D014581 - urticaria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006969:Immediate hypersensitivity
0 Companies
0 Drugs
Success rate
D017445:Vascular skin diseases
0 Companies
0 Drugs
Success rate
D014581:Â
Urticaria
D000080223:Chronic urticaria
0 Companies
0 Drugs
Success rate
D000799:Angioedema
D000096703:Cold urticaria
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Chlorpheniramine | Chlorpheniramine |  | 1982-01-01 |  |  |
| Dextromethorphan, Pseudoephedrine, Brompheniramine | Dimetane-dx |  | 1984-08-24 |  |  | |
| Diphenhydramine | Diphenhydramine |  | 1982-01-01 |  |  | |
| Abbott Biotherapeutics | Promethazine | Promethazine |  | 1982-01-01 |  |  |
| Able Laboratories | Promethazine | Promethazine |  | 2003-02-27 |  |  |
| Acella Pharmaceuticals | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2016-09-20 |  |  |
| Hydrocodone, Chlorpheniramine | Hydrocodone Chlorpheniramine |  | 2017-06-09 |  |  | |
| Alkem Laboratories | Dextromethorphan, Pseudoephedrine, Brompheniramine | Brompheniramine Maleate, Pseudoephedrine Dextromethorphan |  | 2020-07-14 |  |  |
| Allergan | Cetirizine | Cetirizine |  | 2010-02-02 |  |  |
| Chlorpheniramine | Chlorpheniramine |  | 1982-01-01 |  |  | |
| Clemastine | Clemastine |  | 1993-10-31 |  |  | |
| Cyproheptadine | Cyproheptadine |  | 1982-01-01 |  |  | |
| Desloratadine | Desloratadine Actavis |  | 2012-01-13 |  |  | |
| Diphenhydramine | Diphenhydramine |  | 1982-01-01 |  |  | |
| Loratadine | Loratadine |  | 2003-11-03 |  |  | |
| Promethazine | Prometh |  | 1982-01-01 |  |  | |
| Promethazine | Promethazine |  | 2003-06-24 |  |  | |
| Codeine, Promethazine | Promethazine Codeine |  | 1984-10-31 |  |  |
1
2
3
4
5
6
...
17
>
Clinical Trials
Historical Success Rate
Phase 1
80%4/5
Phase 2
17%2/12
Phase 3
83%34/41
Approved: 25Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
12
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use